Beruflich Dokumente
Kultur Dokumente
T u r n i n g i n n o v a t i o n i n t o e c o n o m i c g r o w t h
www.ghbn.org
T u r n i n g i n n o v a t i o n i n t o e c o n o m i c g r o w t h
Contents
Who we are................................ 2
What we do................................ 4
Formula for success.................. 10
Welcome to the inaugural annual report of the Golden Horseshoe Biosciences Network (GHBN).
Eye on the future...................... 12
Networks are all about new partnerships – bringing people and organizations together to About us.................................. 13
create opportunities and solve problems, especially when it comes to large scale change.
That’s something we really believe in and are passionate about – in the same way that we’re
passionate about the economic potential of the Golden Horseshoe.
Email: paredes@mcmaster.ca
Thank you to the team, the Board of Directors and our partner networks for playing such a
Tel: (905) 525-9140 ext. 26602
valuable role in the GHBN’s success. As we go forward, we will maintain the momentum by
Fax: (905) 528-3999
continuing to focus on the needs of our clients; and along with our partners we will enjoy
www.ghbn.org
listening to the buzz of entrepreneurial activity that will define the Golden Horseshoe’s
knowledge-based economy of tomorrow.
www.ghbn.org
who we are
The Golden Horseshoe Biosciences Network (GHBN) is a regional network
of research organizations, companies, universities, and economic developers
involved in biosciences, biotechnology and related fields. Through relationship-
building and entrepreneurial support, the aim is to spur innovation, form new
ties and develop new research and investment to ensure a thriving innovation
centre in the Golden Horseshoe.
How we started
The GHBN’s history dates back to 2002, when the Province of Ontario
announced a biotechnology strategy to attract growth and investment, and
ultimately make Ontario one of the most competitive jurisdictions in North
America for biotechnology. The GHBN was incorporated in 2005 to execute the
strategy in the Golden Horseshoe, with a mandate to identify the commercial
potential of initiatives within hospitals, universities and research institutions;
develop an entrepreneurial culture; create opportunities for start-ups; and put
the supports in place to help small businesses grow. This was a significant
undertaking, with functional connections among stakeholder groups virtually
non-existent, and success ultimately requiring fundamental shifts in mindsets,
working relationships and funding models.
”
to effect change”
Lauren Cuddy
Executive Vice President, i3 Innovus,
and Chair of the Board of Directors,
Golden Horseshoe Biosciences Network
(GHBN)
what we do
“
With universities
n Networking and events, to create linkages within and outside the region
n Communicating government programs
their scientific strengths in
n Facilitating business support infrastructure
industry circles, it’s been n Creating new business opportunities
n Helping companies grow, through mentoring and resource identification
very difficult to find out
n Meeting entrepreneurial needs, at all stages of growth
about current research
”
through proactive communication about individual companies
n Work with decision makers at all levels of government to be well-informed about
programs and opportunities, and well-poised to help clients gain access
n Participate in a broad spectrum of partner events and initiatives across Ontario, the
Steve Boyajian Northeastern U.S. and Europe, to further enhance the realm of resources for clients
Business Development Manager,
Activation Labs The GHBN’s own roster of events is also central to the overall networking effort, with
more than 20 events hosted annually and increasing participants, requests to partner,
and requests to assist other Regional Innovation Networks (RINs) in establishing similar
programs for their clients. Key successes to date include:
Going forward, the GHBN also intends to broaden the scope of learning and networking opportunity
for entrepreneurs through more event-based collaboration. Partner organizations will include:
“
n BioEnterprise, an agency established to help promote the creation, growth and expansion
of businesses in the Agri-Food and Agri-Life Sciences and Bio-Product Industries
n Regional and national angel investment networks
n Innovation Synergy Centre Markham (ISCM)
n Industry associations focused on materials and manufacturing,
“Through the GHBN events
such as the Institute of Electrical Engineers (IEE)
n Regional networks with demonstrated success in strengthening various innovation I have a much improved
sectors relevant to innovation and the Golden Horseshoe, such as the Business
understanding of the
Information Technology Network (BitNet)
challenges and opportunities
Communicating government programs that companies face, and
As a Regional Innovation Network (RIN), the GHBN is uniquely positioned to communicate where there are opportunities
government programs in both directions – to entrepreneurs and small companies that need them,
for my organization to identify
and back to government where direct insight about what companies need helps to inform program
improvements. Among bioscience companies, there’s limited knowledge of government programs potential solutions. The more
designed to help them grow. The GHBN plays a key role in creating awareness of programs including:
I know, the more I’m able to
n Scientific Research and Experimental Development (SR&ED) tax credits
serve their interests.”
n Industrial Research Assistance Program (IRAP), through which the GHBN
also administers $50K year for mentorship programs
”
n Sustainable Development Technology Canada (SDTC)
n Ontario Commercialization Strategy Programs, including:
- Ontario Centres of Excellence (OCE)
- Ontario Commercialization Investment Funds (OCIF)
Yvonne Gruenthaler
- Next Generation of Jobs Fund Trade Commissioner Life Sciences,
- Business Mentorship and Entrepreneurship Program (BMEP) Science and Innovation, Regional Office
of the Trade Commissioner Service,
Following awareness, the GHBN provides hands-on assistance with program application processes, Ontario Region, Foreign Affairs and
International Trade Canada
as well as one-on-one business development consulting. The GHBN’s goal is to ensure that our
companies are as prepared as possible to reach the next level of growth. Companies that have
received significant funding through these and related programs to date include:
The growth achievements of these companies are big wins for the GHBN, and the network
looks forward to providing further value through the addition of an Experts-in-Residence
program beginning in 2009.
“
resources to develop commercially successful products and services. Resources include
laboratories, scientific equipment and research requirements as well as business
mentoring and support services. In addition, MBIC offers shared administrative facilities
and office equipment, executive meeting space, business advice and referral services,
To capture the life sciences networking opportunities, and programs for off-site clients.
”
Bioenergy advancement initiative
In partnership with Vineland Research and Innovation Centre, the GHBN is playing a
facilitation role in establishing an energy-focused demonstration initiative to benefit
the wine, horticulture and agriculture industries in Niagara, as well as new economic
development and training opportunities. The project is in the formative phases with
Nick Markettos next steps including an RFP to secure a consultant to manage execution of the
Director, Strategic Partnerships and McMaster
Innovation Park Liaison, McMaster University
demonstration project.
and Vice-President of Business Development,
Board of Directors, Golden Horseshoe
Biosciences Network (GHBN)
Helping companies grow
Entrepreneurial growth and development in biosciences is the key driver behind the GHBN program
and services offering. The approach is a combination of one-on-one business consulting and linkages
to partner resources. Business consulting may include business plan review, deciphering applicable
government programs and assisting with applications, providing insight into key conference and
trade show opportunities, and preparation for venture capital (VC) presentations. Linkages to partner
resources may include opening doors to knowledge and financial resources. With an individual
approach to the needs of each entrepreneur or growing company, the GHBN is able to add value
throughout the various stages of growth.
In the last year, the number of companies the GHBN has worked with has more than doubled,
from nine in 2006 to 21 in 2007. These companies include:
Now poised for investment, the company has secured more than $1M from investors.
“
The GHBN has been invaluable in promoting the vision of our
”
Anders Elmik, COO Medtel Software & Adjuvant Informatics
n Atreo Medical Inc., a medical devices company responsible for CPRGloveTM, a portable,
inexpensive, and adaptive device designed to greatly improve the success rate of cardio-
pulmonary resuscitation (CPR), and useful in CPR emergencies as well as training/testing
scenarios. A business mentor from the company’s early days, the GHBN has been
instrumental in helping Atreo:
- Develop its business plan
- Prepare for investor presentations
- Facilitate a clinical trial
- Secure a combined 775K in funding from Ontario Centres of Excellence (OCE) the Investment
Accelerator Fund, and the GHBN/HTX/HHS/McMaster University Venture Funding Pilot
“ GHBN has been providing support and guidance to Atreo from the very
“
beginning. They worked with us to develop our first business plan and
investor pitch presentation, then helped us connect with the right people
and organizations to take us to the next level, including financing and
participation in the new clinical trials program GHBN is running in
After eight years of research partnership with HTX, McMaster University and Hamilton Health Sciences.
GHBN has provided all of this to us, and has asked nothing in return. It is
”
and working with patients,
this altruistic spirit that sets GHBN far apart from other organizations.
we have a full-scale research Sarah Smith, B.Eng, COO, Atreo Medical Inc.
and development program n Bee Biomedical Inc., a small biopharmaceutical company, is involved in the manufacturing
of anti-viral, anti-inflammatory topical skin therapies based on the bioactive compounds of
underway thanks in large
honey and propolis. The GHBN is helping the company to:
part to the mentorship and - Become investor-ready
- Identify new financial resources
connections provided through
- Access consulting services through the Business Mentorship and Entrepreneurship
the GHBN. Their assistance Program (BMEP) offered through the Industrial Research Assistance Program of the
National Research Council (NRC-IRAP)
in deciphering government - Facilitate a clinical trial
programs and connecting me to - Gain contacts at the Agriculture Council of Canada and Ontario Centres of Excellence (OCE)
Funding results to date total almost $400K in development research.
the right people within the right
”
continuing relationship with the
commercial product is near.
GHBN and highly value their Katrina Brudzynski, Ph.D, Scientist, Bee-Biomedicals Inc. Adjunct Professor, Brock University
assistance to date. n TakeControl Cosmedix Inc.®, a medical devices company focused on silicone-based
camouflage for disfigurations caused by accidents, burns, skin cancer etc. A key relationship
”
facilitator for the company, the GHBN helped TakeControl to navigate through municipal
and provincial funding programs, resulting in:
- An R&D program with McMaster University and Ontario Centres of Excellence (OCE)
funding of $15K under the Interact Program
Brandy Gowling, CEO / Founder - $2500 from the Industrial Research Assistance Program of the
TakeControl Cosmedix Inc.® National Research Council (NRC-IRAP)
- A clinical trial
- Clinic space allocation in the Hamilton Hospitals Assessment Centre,
under the umbrella of the Hamilton Health Sciences Corporation
by the numbers Fast Facts
formula for success
Knowing our clients
“
“ The GHBN stands out because they really understand their clients.
”
Brad DeFoe, Manager/A, Commercialization Branch, Ontario Ministry of Research and Innovation
A 2005 survey of stakeholders and clients in the biomedical and medical space in the
Over the last few years, Buffalo Golden Horseshoe was the foundation for the GHBN’s current database. The next survey
– planned for 2009 – will incorporate the convergent space around bio, providing greater
Niagara has formed a very
insight into regional business development opportunities. While the number of companies in
positive working relationship the database will increase, the approach will remain highly focused and knowledgeable of
individual company needs, to ensure the right resources are in place to continue propelling
with our regional counterparts
companies forward.
from Southern Ontario, including
capacity of the bi-national region. n A speaker panel series with partners BioDiscovery Toronto, Western Greater Toronto
Area Convergence Centre (WGTACC), YORKbiotech, and the Institute of Electrical
”
Engineers (IEE)
n Government program information sessions in partnership with the Health Technology
Exchange (HTX) and MaRS Discovery District
David S. Tyler,
Business Development Manager Internationally, the GHBN is focused on opening the doors to new markets and creating
Life Sciences, Buffalo Niagara Enterprise (BNE) reciprocal training opportunities, through:
“networking, partnering,
10
Focusing on what we’re good at
As a RIN the role of GHBN is to connect companies to the services they need to grow,
which requires us to acquire an in-depth of understanding of the company and use
“
GHBN knows the companies
”
n Producing a robust quarterly newsletter, Bio-Matrix
n Developing original content for top industry publications including Biotechnology
Focus, Canada’s leading news authority on the Canadian life sciences industry
Tools that help build knowledge – and knowledge flow – are a critical part
Patricia Cosgrove
of a successful Regional Innovation Network (RIN). Feedback on the GHBN’s International Marketing Consultant,
communication tools to date has been excellent, with audiences becoming increasingly Ontario Exports Inc
informed about the level of bioscience innovation happening in the Golden Horseshoe.
Going forward, the GHBN’s communication tools will be enhanced through new
initiatives to produce:
collaborating”
11
eye on the future
“
By adopting an inclusive
powerhouse in the province. To be successful it will be important to ensure financial resources are maintained in
accordance with the program and services offering. As more companies come into
the fold, the GHBN also needs to grow with additional well-qualified staff. Possible
”
adjustments toward a membership model will enhance the breadth and depth of client
engagement, enabling:
Within bioscience, medical and assistive devices currently provide the greatest potential for
the region, with a relatively short return on investment timeline, and an excellent fit with
academic, research and manufacturing strengths. As such bioscience commercialization
will remain the network’s core focus, though the convergent space accompanying the
new synergy centre will necessitate build-out to embrace innovation and entrepreneurism
more broadly.
According to “creative class” guru and University of Toronto Professor Richard Florida,
the economic activity, number of patents, rate of growth and location of the Golden
Horseshoe make it a virtual shoe-in to be part of a major economic boom, although
ultimate success will be determined by broad-based cultural support of innovation.
The GHBN’s role in achieving that success for the Golden Horseshoe is centred on active
promotion and partnership to identify and access the knowledge and financial resources
required by entrepreneurs.
The strength of the region is in its ability to be convergent. The GHBN looks forward to the
buzz created by a bustling new synergy centre as well as ongoing partnerships to support
creation of a prosperous knowledge-based environment in the Golden Horseshoe. There is
great potential here.
here”
PreMD Inc. Professor of Medicine
McMaster University Waterloo Research and Technology Park
Neil Everson
Executive Director Director Accelerator
Economic Development Department Population Health Research Institute
YORKbiotech
City of Hamilton VP of Research,
Yousef Haj-Ahmad PhD Chief Scientific Officer
President / CEO Hamilton Health Sciences
Norgen Biotek Corp.
13
T u r n i n g i n n o v a t i o n i n t o e c o n o m i c g r o w t h
Tel: (905) 525-9140 ext. 26602 | Fax: (905) 528-3999 | Email: info@ghbn.org | www.ghbn.org